insulin

Novo Nordisk said on Thursday it would offer free, one-time supply of insulin to people in immediate need and at risk of rationing the medication, the rising price of which has attracted fierce criticism from lawmakers...

The amount of insulin needed to effectively treat type 2 diabetes will rise by more than 20% worldwide over the next 12 years, but without major improvements in access, insulin will be beyond the reach of...

News Hour: Novo Nordisk today announced that the China Food and Drug Administration (CFDA) has approved Tresiba® (insulin degludec) for the treatment of diabetes in China. Tresiba® is a new-generation, once-daily basal insulin with an ultra-long duration of action which allows...

News Hour: Sanofi announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion for the marketing authorization of Insulin lispro Sanofi® (insulin lispro 100...

News Hour: When a patient with type 2 diabetes lives with their spouse, their risk of being overweight halves compared with those patients with type 2 diabetes who are single. Among patients with type 2 diabetes...